Table 5 The levels of Ca, P, and iPTH in different-age groups.
From: The current status of chronic kidney disease-mineral and bone disorder management in China
All patients (n = 7053) | 18–44 (n = 1414) | 45–59 (n = 3016) | ≥ 60 (n = 2623) | P | |
|---|---|---|---|---|---|
Corrected Ca patients, n | 5583 | 1049 | 2388 | 2146 | |
Corrected Ca (mmol/L) | 2.21 (2.05, 2.37) | 2.22 (2.06, 2.39) | 2.21 (2.06, 2.37) | 2.20 (2.05, 2.36) | 0.041 |
Corrected Ca, n (%) | |||||
< 2.1 | 1747 (31.3) | 308 (29.4) | 738 (30.9) | 701 (32.7) | 0.145 |
2.1–2.5 | 3214 (57.6) | 611 (58.2) | 1379 (57.7) | 1224 (57.0) | 0.788 |
> 2.5 | 622 (11.1) | 130 (12.4) | 271 (11.3) | 221 (10.3) | 0.192 |
P patients, n | 6413 | 1279 | 2747 | 2387 | |
P (mmol/L) | 1.78 (1.40, 2.18) | 1.89 (1.49, 2.30) | 1.83 (1.44, 2.22) | 1.67 (1.32, 2.07) | < 0.001 |
P, n (%) | |||||
< 0.87 | 260 (4.1) | 37 (2.9) | 92 (3.3) | 131 (5.5)a | < 0.001 |
0.87–1.45 | 1561 (24.3) | 255 (19.9) | 614 (22.4) | 692 (29.0)a | < 0.001 |
1.46–1.78 | 1423 (22.2) | 257 (20.1) | 599 (21.8) | 567 (23.8)b | 0.032 |
> 1.78 | 3169 (49.4) | 730 (57.1) | 1442 (52.5) | 997 (41.8)a | < 0.001 |
iPTH patients, n | 5610 | 1154 | 2405 | 2051 | |
iPTH (pg/mL) | 314.3 (164.0, 560.0) | 400.7 (217.9, 681.0) | 314.3 (164.0, 560.0) | 266.1 (146.1, 463.1) | < 0.001 |
iPTH, n (%) | |||||
< 150 | 1249 (22.3) | 191 (16.6) | 527 (21.9) | 531 (25.9)a | < 0.001 |
150–300 | 1448 (25.8) | 222 (19.2) | 612 (25.4) | 614 (29.9)a | < 0.001 |
301–600 | 1639 (29.2) | 394 (34.1)c | 676 (28.1) | 569 (27.7) | < 0.001 |
601–800 | 439 (7.8) | 111 (9.6) | 192 (8.0) | 136 (6.6)b | 0.010 |
> 800 | 835 (14.9) | 236 (20.5) | 398 (16.5) | 201 (9.8)a | < 0.001 |
